Jeffrey Tarrant, Pioneering Hedge Fund Investor, Dies at 63
(Bloomberg) -- Jeffrey Tarrant, a leading hedge fund investor who backed managers including Bill Ackman and Marc Lasry before they were stars, has died. He was 63.
Tarrant died on Aug. 5 at his home in Bridgehampton, New York, from a brain tumor that was first diagnosed and treated in 2017, according to a statement Wednesday from Protege Partners, the firm he founded.
“Jeff has been a pioneer and a significant influence in the development of the modern-day hedge fund seeding industry with great vision for the future,” said Carol O'Donnell, chief executive officer of New York-based Protege. “It has been a privilege to know and work with him.”
Tarrant was involved in the hedge fund industry for more than three decades. After graduating from University of California at Davis and getting an MBA from Harvard Business School in 1985, he joined Berkeley Asset Management, where he co-managed the Sequoia Fund, one of the first fund of hedge funds in the U.S. After managing money for several private families, he formed Protege in 2002 to farm out money to hedge funds.
Industry Leaders
Tarrant seeded or was an early investor in managers including Ackman, Lasry and Jamie Dinan. Often at the forefront of spotting profitable trades or investment trends, Tarrant was the lead investor in John Paulson's fund, which made billions betting against U.S. subprime mortgages. More recently, he founded Mov37 to invest in funds that use artificial intelligence.
In early 2008, Tarrant and Protege made a high-profile wager with investor Warren Buffett. The billionaire bet Protege that over a 10-year period, the S&P 500 Index would outperform a portfolio of hedge funds. The hedge funds lost, and more than $2.2 million went to Buffett's charity of choice, Girls Inc. of Omaha.
Tarrant's philanthropic pursuits included producing and financing documentaries exploring social issues. He also helped found Absolute Return for Kids in 2002, a U.K.-based charity that raised more than $120 million over a decade. In 2011, he joined the board of global human rights group Witness at the invitation of co-founder and musician Peter Gabriel.
Tarrant is survived by daughters Paulina and Fabienne and sisters Dorothy and Lynn. Donations in his memory can be made to two medical research groups: Dr. David Reardon's Research Fund at the Dana-Farber Cancer Institute in Boston, and the Global Coalition for Adaptive Research in Los Angeles.
To contact the reporters on this story: Melissa Karsh in New York at mkarsh@bloomberg.net;Katherine Burton in New York at kburton@bloomberg.net
To contact the editors responsible for this story: Alan Mirabella at amirabella@bloomberg.net, Josh Friedman
©2019 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.